Evidence map›Paper›PMID 41198240›Full record

Trial reportJournal of nuclear medicine : official publication, Society of Nuclear Medicine2026

Diagnostic Performance of [

Kerstin Michalski, Florian P Reiter, Aleksander Kosmala, Philipp E Hartrampf, Simone Seifert, Charis Kalogirou, Stefan Kircher, Thorsten A Bley, Andreas Geier, Alexander Meining and 3 more

Abstract readClinical Trial
In one paragraph

Trial report in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Incidental detection of PDAC viaFrontiers in nuclear medicine · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kerstin MichalskiDepartment of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany; michalski_k@ukw.de.
Florian P ReiterInternal Medicine II, University Hospital Würzburg, Würzburg, Germany.
Aleksander KosmalaDepartment of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
Philipp E HartrampfDepartment of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
Simone SeifertDepartment of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
Charis KalogirouDepartment of Urology, University Hospital Würzburg, Würzburg, Germany.
Stefan KircherDepartment of Pathology, University of Würzburg, Würzburg, Germany.
Thorsten A BleyDepartment of Diagnostic and Interventional Radiology, University Hospital Würzburg, Würzburg, Germany.
Andreas GeierInternal Medicine II, University Hospital Würzburg, Würzburg, Germany.
Alexander MeiningInternal Medicine II, University Hospital Würzburg, Würzburg, Germany.
Andreas K BuckDepartment of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
Rudolf A WernerNET-Zentrum Würzburg, European Neuroendocrine Tumor Society Center of Excellence, University Hospital Würzburg, Würzburg, Germany.
Alexander WeichInternal Medicine II, University Hospital Würzburg, Würzburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High expression of prostate-specific membrane antigen (PSMA) is not limited to prostate cancer but can be found in other tumor entities, such as hepatocellular carcinoma (HCC), and could possibly be used for theranostic purposes. Our aim was to investigate the diagnostic potential of the hepatobiliary excreted radiotracer [

Indexed as

Antigens, SurfaceCarcinoma, HepatocellularGlutamate Carboxypeptidase IILiver NeoplasmsNiacinamideOligopeptidesPositron Emission Tomography Computed TomographyAgedFemaleFluorine RadioisotopesHumansMaleMiddle AgedProspective StudiesAntigens, SurfaceFluorine RadioisotopesFOLH1 protein, humanGlutamate Carboxypeptidase IINiacinamideOligopeptidesPSMA-1007[18F]PSMA-1007 PET/CThepatocellular carcinomaoutcome predictiontheranostic

Identifiers

PMID41198240
PMCPMC12766888

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.